TOKYO & PALO ALTO, Calif.--(BUSINESS WIRE)--Heartseed Inc. ("Heartseed"), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure and I Peace Inc. ("I Peace"), a ...
There is a high unmet need for accessible, affordable, and high-quality fertility care, as approximately 1 in 6 people are affected by infertility worldwide. While meiotic failure is a major cause of ...
New methods for deriving macrophages from induced pluripotent stem cells are easier to scale and provide more clinically relevant data. Induced pluripotent stem cells (iPSCs) have given scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results